494799-65-4

Basic information

• Product Name: 1H-Pyrrolo[2,3-b]pyridine, 3-cyclohexyl-
• Synonyms: 1H-Pyrrolo[2,3-b]pyridine, 3-cyclohexyl-;3-Cyclohexyl-1H-pyrrolo[2,3-b]pyridine
• CAS NO: 494799-65-4
• Molecular Formula: C₁₃H₁₆N₂
• Molecular Weight: 200.27954
• Mol File: 494799-65-4.mol
• Article Data: 2

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1H-Pyrrolo[2,3-b]pyridine, 3-cyclohexyl-(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrrolo[2,3-b]pyridine, 3-cyclohexyl-(494799-65-4)
• EPA Substance Registry System: 1H-Pyrrolo[2,3-b]pyridine, 3-cyclohexyl-(494799-65-4)

Safety Data

• Hazardous Substances Data: 494799-65-4(Hazardous Substances Data)

Usage

Chemical class

pyrrolopyridine derivatives
A heterocyclic compound with a pyrrole ring fused to a pyridine ring.

Structure

3-cyclohexyl substitution
A cyclohexyl group is present at the 3 position of the pyrrolopyridine structure.

Potential applications

pharmaceuticals and agrochemicals
May exhibit biological activity and is of interest for further research and development as a potential drug candidate or as a precursor for the synthesis of other compounds with desired properties.

Upstream product

• 108-94-1 cyclohexanone 
• 271-63-6 7-Azaindole 
• 494799-64-3 3-cyclohexenyl-1H-pyrrolo[2,3-b]pyridine 

Downstream Products

• 494799-66-5 3-cyclohexyl-1H-pyrrolo[2,3-b]pyridine 7-oxide 
• 1049797-29-6 13-Cyclohexyl-6-(((2R,6S)-2,6-dimethyl-4-morpholinyl)carbonyl)-3-(methyloxy)-7H-pyrido[3',2':4,5]pyrrolo[2,1-a][2]benzazepine 
• 1049797-07-0 13-Cyclohexyl-10-((((dimethylamino)sulfonyl)amino)carbonyl)-3-(methyloxy)-7H-pyrido[3',2':4,5]pyrrolo[2,1-a][2]benzazepine-6-carboxylic acid 
• 1049797-05-8 Methyl 13-cyclohexyl-10-((((dimethylamino)sulfonyl)amino)carbonyl)-3-(methyloxy)-7H-pyrido[3',2':4,5]pyrrolo[2,1-a][2]benzazepine-6-carboxylate 
• 1049797-20-7 Methyl 13-cyclohexyl-10-((((dimethylamino)sulfonyl)amino)carbonyl)-3-(methyloxy)-7H-pyrido[3',2':4,5]pyrrolo[2,1-a][2]benzazepine-6-carboxylate 9-oxide 
• 1049797-09-2 13-Cyclohexyl-N-((dimethylamino)sulfonyl)-6-(((2R,6S)-2,6-dimethyl-4-morpholinyl)carbonyl)-3-(methyloxy)-7H-pyrido[3',2':4,5]pyrrolo[2,1-a][2]benzazepine-10-carboxamide 
• 1049797-11-6 13-cyclohexyl-N-((dimethylamino)sulfonyl)-3-(methyloxy)-6-(((3R,5S)-3,4,5-trimethyl-1-piperazinyl)carbonyl)-7H-pyrido[3',2':4,5]pyrrolo[2,1-a][2]benzazepine-10-carboxamide 
• 1049796-94-2 7-benzyl-2-bromo-3-cyclohexyl-7H-pyrrolo[2,3-b]pyridine 
• 1049797-00-3 C₂₁H₂₂N₂O₂ 
• 1049796-88-4 2-bromo-3-cyclohexyl-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[2,3-b]pyridine 7-oxide 
• 1049796-96-4 2-(7-benzyl-3-cyclohexyl-7H-pyrrolo[2,3-b]pyridin-2-yl)-5-methoxybenzaldehyde 
• 1049797-22-9 C₂₄H₂₈N₄O₆S 
• 1049796-90-8 2-bromo-3-cyclohexyl-6-(N,N-dimethylsulfamoylcarbamoyl)-1-((2-(trimethylsilyl)ethoxy)methyl)-1H-pyrrolo[2,3-b]pyridine 7-oxide 
• 1049797-03-6 C₃₀H₄₂N₄O₆SSi 

Relevant articles and documents

Compounds for the Treatment of Hepatitis C

The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.